What is the incidence of bile acid diarrhea in patients after terminal ileal resection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Bile Acid Diarrhea After Terminal Ileal Resection

Bile acid diarrhea occurs in over 80% of patients following terminal ileal resection, with the vast majority (91-100%) demonstrating severe bile acid malabsorption on diagnostic testing. 1, 2

Documented Incidence Rates

The incidence is remarkably high and well-established across multiple guideline sources:

  • 91-100% of patients with terminal ileal resection for Crohn's disease demonstrate abnormal SeHCAT retention (<15%), indicating at least mild bile acid malabsorption 1
  • 87-92% have severe malabsorption (SeHCAT retention <10%) 1
  • 76-82% of patients with terminal ileal resection for reasons other than Crohn's disease develop bile acid diarrhea 1
  • 97% of Crohn's patients with ileal resection had SeHCAT retention <10%, and 93% had retention <5% in one cohort study 3

Why This Occurs

The terminal ileum contains the apical Na+-dependent bile salt transporter responsible for reabsorbing over 90% of bile acids 1, 4. When this segment is resected, unabsorbed bile acids reach the colon where they stimulate fluid, mucus, and sodium secretion while increasing gastrointestinal motility 2. This mechanism is nearly universal after terminal ileal resection, making bile acid diarrhea the expected outcome rather than a complication 1.

Correlation with Resection Length

There is a modest but significant correlation between the length of ileal resection and severity of bile acid malabsorption (Spearman's rho -0.392, P=0.0001) 3. However, even relatively short resections can cause severe symptoms, as the active transport mechanisms are highly localized to the terminal ileum 1.

Clinical Implications

Diagnostic testing may not be necessary before initiating treatment in patients with documented terminal ileal resection, given the extremely high pretest probability 1. The Canadian Association of Gastroenterology specifically notes that in patients with ileal resection, there is an extremely high risk of bile acid diarrhea, and diagnostic testing may not be necessary before treatment 1.

Response to bile acid sequestrants occurs in approximately 67% of patients with ileal resection, though this response rate is not dependent on the severity of SeHCAT retention values 3. First-line treatment with cholestyramine 4g once or twice daily, titrated to 2-12g/day based on response, is recommended 2.

Important Caveat

Do not use bile acid sequestrants if the patient has extensive ileal resection (>100 cm) due to risk of worsening steatorrhea from binding of remaining bile acids needed for fat absorption 5. In these cases, the primary problem shifts from bile acid diarrhea to fat malabsorption 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bile Acid Diarrhea Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Advances in understanding of bile acid diarrhea.

Expert review of gastroenterology & hepatology, 2014

Guideline

Bile Acid Diarrhea Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.